Molecular Partners (MOLN) Stock Chart & Stock Price History $3.80 -0.09 (-2.21%) As of 11:59 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Molecular Partners Stock Price Performance The Molecular Partners (MOLN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 25.56%, with a year-to-date return of -19.92%. In the past month, the stock has increased 0.77%, reflecting recent market activity. As of the latest close, Molecular Partners traded at $3.89 with a market cap of $157.08 million and volume of 9,696 shares. Receive MOLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+2.92%1 Month Performance+0.77%3 Month Performance+4.25%Year-To-Date Performance-19.92%1 Year Performance-25.56% MOLN Stock Chart for Thursday, October, 9, 2025 MOLN Chart by TradingView Molecular Partners Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/08/2025$3.71$3.89+4.85%$4.00$3.729,696 shs$157.08 million10/07/2025$3.72$3.71-0.30%$3.75$3.702,181 shs$149.81 million10/06/2025$3.70$3.72+0.68%$3.75$3.702,361 shs$150.24 million10/03/2025$3.73$3.70-1.02%$3.75$3.711,531 shs$149.23 million10/02/2025$3.71$3.73+0.65%$3.76$3.702,647 shs$150.78 million10/01/2025$3.71$3.71$3.76$3.681,452 shs$149.81 million09/30/2025$3.74$3.71-0.80%$3.80$3.653,651 shs$149.79 million09/29/2025$3.85$3.74-2.86%$3.82$3.68409 shs$151.02 million09/26/2025$3.73$3.85+3.36%$3.85$3.622,749 shs$155.46 million09/25/2025$3.68$3.73+1.20%$3.61$3.57876 shs$150.42 million Get the Latest News and Ratings for MOLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. 09/24/2025$3.76$3.68-1.97%$3.79$3.68871 shs$148.62 million09/23/2025$3.72$3.76+0.91%$3.68$3.6410,985 shs$151.63 million09/22/2025$3.74$3.72-0.40%$3.68$3.6410,985 shs$150.25 million09/19/2025$3.70$3.74+1.11%$3.85$3.661,547 shs$150.86 million09/18/2025$3.72$3.70-0.70%$3.70$3.694,160 shs$149.20 million09/17/2025$3.70$3.72+0.57%$3.73$3.643,702 shs$150.25 million09/16/2025$3.76$3.70-1.46%$3.73$3.643,702 shs$149.41 million09/15/2025$3.68$3.76+2.15%$3.79$3.731,078 shs$151.63 million09/12/2025$3.74$3.68-1.58%$3.74$3.722,286 shs$148.44 million09/11/2025$3.72$3.74+0.38%$3.76$3.711,638 shs$150.82 million09/10/2025$3.78$3.72-1.43%$3.85$3.692,889 shs$150.25 million09/09/2025$3.59$3.78+5.15%$3.72$3.72944 shs$152.43 million09/08/2025$3.58$3.59+0.28%$3.72$3.582,037 shs$144.54 million Related Companies Opthea Stock Chart Aquestive Therapeutics Stock Chart COMPASS Pathways Stock Chart Inventiva Stock Chart Corvus Pharmaceuticals Stock Chart Organogenesis Stock Chart Zevra Therapeutics Stock Chart CytomX Therapeutics Stock Chart Esperion Therapeutics Stock Chart Compass Therapeutics Stock Chart Receive MOLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MOLN) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
